Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lalit Kumar

Showing results (841-850 of 977) with videos related to

Pageof 98
Sort By:
3 Biotech|November 6, 2023
Enhancing temozolomide antiglioma response by inhibiting O6-methylguanine-DNA methyltransferase with selected phytochemicals: in silico and in vitro approachR J A Vibhavari, Vanishree Rao, Sri Pragnya Cheruku, et al.
European Journal of Haematology|December 17, 2013
Immunophenotypic analysis of T-acute lymphoblastic leukemia. A CD5-based ETP-ALL perspective of non-ETP T-ALLAnita Chopra, Sameer Bakhshi, Suman Kumar Pramanik, et al.
JCO Global Oncology|February 16, 2023
Cost-Effectiveness of the First Line Treatment Options For Metastatic Renal Cell Carcinoma in IndiaDharna Gupta, Ashish Singh, Nidhi Gupta, et al.
BMJ Supportive & Palliative Care|January 28, 2026
Breaking bad news and the cost of caring on physicians: a systematic scoping reviewCheng Yat Tan, Nicholas Wei Hong Thum, Trivikram Mohan, et al.
BMC Medical Education|September 15, 2024
Peer mentorship and professional identity formation: an ecological systems perspectiveLalit Kumar Radha Krishna, Nur Amira Binte Abdul Hamid, Gillian Li Gek Phua, et al.
International Journal of Laboratory Hematology|June 14, 2024
Implementation of the recommended immunohistochemistry algorithm for classification of peripheral T-cell lymphoma, not otherwise specified into the prognostically significant GATA3 and TBX21 subtypesSurabhi Jain, Aijaz Ahmad, Ambreen Jan, et al.
Annals of Hematology|July 8, 2021
Critical evaluation of the utility of pre- and post-therapy immunophenotypes in assessment of measurable residual disease in B-ALLNupur Das, Ritu Gupta, Sanjeev Kumar Gupta, et al.
Journal of Medicinal Chemistry|August 13, 2024
Development of Brain Penetrant Pyridazine Pantothenate Kinase ActivatorsRajendra Tangallapally, Chitra Subramanian, Mi-Kyung Yun, et al.
Plos One|July 5, 2013
Designed Chemical Intervention with Thiols for Prophylactic ContraceptionMonika Sharma, Lokesh Kumar, Ashish Jain, et al.
Microbiology and Immunology|May 20, 2026
Monitoring Rubella Immunity and Transmission in Central India Amidst Elimination EffortsVijay Pratap Singh, Kavita N Singh, Deepica Tirkey, et al.
Pageof 98

Showing results (841-850 of 977) with videos related to

Sort By:
Pageof 98
3 Biotech|November 6, 2023
Enhancing temozolomide antiglioma response by inhibiting O6-methylguanine-DNA methyltransferase with selected phytochemicals: in silico and in vitro approachR J A Vibhavari, Vanishree Rao, Sri Pragnya Cheruku, et al.
European Journal of Haematology|December 17, 2013
Immunophenotypic analysis of T-acute lymphoblastic leukemia. A CD5-based ETP-ALL perspective of non-ETP T-ALLAnita Chopra, Sameer Bakhshi, Suman Kumar Pramanik, et al.
JCO Global Oncology|February 16, 2023
Cost-Effectiveness of the First Line Treatment Options For Metastatic Renal Cell Carcinoma in IndiaDharna Gupta, Ashish Singh, Nidhi Gupta, et al.
BMJ Supportive & Palliative Care|January 28, 2026
Breaking bad news and the cost of caring on physicians: a systematic scoping reviewCheng Yat Tan, Nicholas Wei Hong Thum, Trivikram Mohan, et al.
BMC Medical Education|September 15, 2024
Peer mentorship and professional identity formation: an ecological systems perspectiveLalit Kumar Radha Krishna, Nur Amira Binte Abdul Hamid, Gillian Li Gek Phua, et al.
International Journal of Laboratory Hematology|June 14, 2024
Implementation of the recommended immunohistochemistry algorithm for classification of peripheral T-cell lymphoma, not otherwise specified into the prognostically significant GATA3 and TBX21 subtypesSurabhi Jain, Aijaz Ahmad, Ambreen Jan, et al.
Annals of Hematology|July 8, 2021
Critical evaluation of the utility of pre- and post-therapy immunophenotypes in assessment of measurable residual disease in B-ALLNupur Das, Ritu Gupta, Sanjeev Kumar Gupta, et al.
Journal of Medicinal Chemistry|August 13, 2024
Development of Brain Penetrant Pyridazine Pantothenate Kinase ActivatorsRajendra Tangallapally, Chitra Subramanian, Mi-Kyung Yun, et al.
Plos One|July 5, 2013
Designed Chemical Intervention with Thiols for Prophylactic ContraceptionMonika Sharma, Lokesh Kumar, Ashish Jain, et al.
Microbiology and Immunology|May 20, 2026
Monitoring Rubella Immunity and Transmission in Central India Amidst Elimination EffortsVijay Pratap Singh, Kavita N Singh, Deepica Tirkey, et al.
Pageof 98